Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0974 with ibuprofen or acetaminophen for acute migraine
2008-004095-43Phase 2Completed
- Sponsor
- MSD
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of telcagepant in migraine (6 arms), sponsored by MSD. Primary endpoints: Pain freedom at 2 hours post dose (MK-0974 + NSAID/acetaminophen vs MK-0974 alone) and Pain freedom at 2 hours post dose (MK-0974 vs placebo). Started Sep 2008; status: completed.
02
Drugs
telcagepant
03
Conditions
migraine
Beyond the preview
Go deeper on 2008-004095-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004095-43.